Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01040650 · ClinicalTrials.gov registry record

Metabolic Features of Post-Myopathy Patients Associated With Statin Treatment

A clinical trial, sponsored by Rockefeller University.

Terminated
Registry status
23
Enrollment target

NCT01040650: Clinical Trial study, sponsored by Rockefeller University.

NCT01040650 is a clinical trial that was terminated before completion, run by Rockefeller University. The registered enrollment target is 23 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01040650 was terminated before completion, sponsored by Rockefeller University.

TERMINATED
Registry status
23 participants
Enrollment target

Study Summary

Statins are a class of drugs given to lower cholesterol. Although statins are considered to be generally safe, some studies show that about 10% of people on statins develop muscle-related symptoms, from fatigue (tiredness), weakness, cramping, pain and sometimes a lifethreatening muscle breakdown condition known as rhabdomyolysis. In some, these symptoms may greatly affect their daily activities. One consideration why symptoms develop in only some patients is that they may have an underlying problem in the way their muscles use fats to produce energy. In these patients, the muscles are not able to fully utilize fats and so they become tired more easily. Fat within the muscle can also affect how your body uses a hormone called insulin, which affects your blood sugar levels. The investigators are specifically interested in previous statin users and determine if the muscle symptoms are related to changes in energy and sugar use. We propose to enroll patients who have developed muscle side effects on previous statin treatment and have since discontinued statin treatment. Our aim is to compare the metabolic parameters in these patients to age and gender-matched normal individuals.

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2009-08
Est. Completion 2012-01
Rockefeller University

117 total trials

Why NCT01040650 stopped before completion

NCT01040650 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 23 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT01040650 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01040650 about?

NCT01040650 is a clinical study titled "Metabolic Features of Post-Myopathy Patients Associated With Statin Treatment". Statins are a class of drugs given to lower cholesterol. Although statins are considered to be generally safe, some studies show that about 10% of people on statins develop muscle-related symptoms, from fatigue (tiredness), weakness, cramping, pain and sometimes a lifethreatening muscle breakdown co...

What is the current status of trial NCT01040650?

This trial is currently terminated. The enrollment target is 23 participants. The study started on 2009-08. Estimated completion is 2012-01.

Who is sponsoring clinical trial NCT01040650?

This trial is sponsored by Rockefeller University, which has 117 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03616041 · 23 participants

    Capsule Endoscopy for Severe Hematochezia

  • NCT04348747 · 23 participants · Phase 2

    Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer

  • NCT04587687 · 23 participants · Phase 2

    Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma

  • NCT04715022 · 23 participants · Phase 1

    Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01040650, the US trial registry maintained by the National Library of Medicine. NCT01040650 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.